SCHEMBL5224985

SCHEMBL5224985

CC(C)(C)N(C(=O)O)[C@@H](Cc1ccccc1)[C@H](O)CNc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
ALDH1A1 P00352 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ABCB1 P08183 1/20 0.38
MAPT P10636 1/20 0.38
BCHE P06276 1/20 0.37
BACE1 P56817 2/20 0.37
RECQL P46063 1/20 0.36
MMP8 P22894 1/20 0.36
CTSL P07711 1/20 0.36
CTSK P43235 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
NPY5R Q15761 1/20 0.36
TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5224996 1.00 OPRM1 (0.39) OPRM1OPRD1OPRK1ALDH1A1NPSR1
SCHEMBL5223463 0.87 OPRD1 (0.41) OPRM1OPRD1OPRK1ABCB1BCHE
SCHEMBL5223473 0.87 OPRD1 (0.41) OPRM1OPRD1OPRK1ABCB1BCHE
SCHEMBL609658 0.84 ANPEP (0.42) OPRM1OPRD1OPRK1ALDH1A1ABCB1
SCHEMBL609656 0.84 ANPEP (0.42) OPRM1OPRD1OPRK1ALDH1A1ABCB1
SCHEMBL4869209 0.82 ABCB1 (0.39) OPRM1OPRD1OPRK1ABCB1BCHE
SCHEMBL5219638 0.82 ADRB3 (0.43) OPRM1OPRD1OPRK1MAPTBCHE
SCHEMBL5223492 0.82 OPRM1 (0.40) OPRM1OPRD1OPRK1ABCB1BCHE
SCHEMBL5223500 0.82 OPRM1 (0.40) OPRM1OPRD1OPRK1ABCB1BCHE
SCHEMBL4869199 0.82 ABCB1 (0.39) OPRM1OPRD1OPRK1ABCB1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed